An evaluation of OPTC and EPYC as candidate genes for high myopia.

Panfeng Wang, Shiqiang Li, Xueshan Xiao, Xiangming Guo, Qingjiong ZhangPubMed 2009

TL;DR

This study investigated two genes, OPTC and EPYC, as potential culprits behind high myopia, a severe form of nearsightedness. While they identified one novel, likely benign variation in OPTC, their findings suggest these genes are not major contributors to high myopia in the Chinese population studied.

What Problem Does This Paper Address?

High myopia is a significant vision impairment that can lead to irreversible blindness, affecting a substantial portion of the global population, particularly in East Asia. Despite its prevalence, the precise genetic underpinnings of high myopia remain largely elusive. Previous research has implicated genes involved in the extracellular matrix (ECM) of the eye, as the sclera and vitreous, which determine eyeball shape, are primarily composed of ECM. Specifically, small leucine-rich repeat proteins (SLRPs) are known to organize collagen fibrils, and defects in these proteins could theoretically lead to altered eye shape and myopia. This paper aims to evaluate two specific SLRP family members, opticin (OPTC) and dermatan sulfate proteoglycan 3 (EPYC), as candidate genes for high myopia.

Methods

The researchers employed a candidate gene approach, focusing on the coding regions and adjacent intronic sequences of the OPTC and EPYC genes. They collected DNA from 93 Chinese patients diagnosed with high myopia (spherical equivalent of -6.00D or worse) and 96 control individuals with normal or slightly myopic vision (-0.50D to +1.00D).

The core methodology involved:

  • DNA Preparation: Genomic DNA was extracted from venous leukocytes.
  • PCR Amplification: Specific primers were designed to amplify the coding exons and flanking intronic regions of OPTC and EPYC. A comprehensive list of primers and their specifications is provided in Table 1.
  • Cycle Sequencing: The amplified DNA products were then analyzed using cycle sequencing to detect any variations.
  • Variation Confirmation: Any detected variations were further confirmed through bidirectional sequencing.
  • Screening in Controls: To assess the frequency of identified variations in the general population, a heteroduplex-single strand conformation polymorphism (heteroduplex-SSCP) analysis was performed on 96 normal controls.
  • In Silico Analysis: The SIFT (Sorting Intolerant From Tolerant) program was used to predict the potential functional impact of any amino acid substitutions.

Datasets

The study utilized two primary datasets:

  • Patient Cohort: DNA samples from 93 Chinese patients with high myopia.
  • Control Cohort: DNA samples from 96 Chinese individuals with normal or low refractive error.

No new datasets were introduced in this paper.

Key Insights and Ideas

  • SLRPs as Myopia Candidates: The study builds on existing knowledge linking ECM proteins to eye development and hypothesizes that SLRPs, like OPTC and EPYC, could be involved in high myopia.
  • Focus on Specific SLRPs: The paper narrows the investigation to two specific class III SLRPs, OPTC and EPYC, which are known to be expressed in ocular tissues.
  • Novelty in OPTC Variation: The identification of a novel heterozygous variation (c.491G>T, p.Arg164Leu) in the OPTC gene in one high myopia patient is a key finding, though its significance is questioned.
  • Conserved Residue and Functional Prediction: The identified OPTC variation involves a change in a conserved arginine residue to leucine. While SIFT predicted this change to be tolerated, the authors acknowledge the limitations of such predictions.
  • EPYC's Elusive Exon 5: The inability to amplify exon 5 of the EPYC gene due to its high AT content highlights a technical challenge that may have limited the comprehensive analysis of this gene.
  • Polymorphism vs. Pathogenic Mutation: The study distinguishes between a novel, potentially disease-causing variant and a known, common polymorphism (c.803T>C in OPTC), noting similar frequencies in both patients and controls for the latter.

Key Results

  • OPTC Variations: Two variations were identified in the OPTC gene:
  • A novel heterozygous missense variation, c.491G>T (p.Arg164Leu), was found in one out of 93 high myopia patients. This variation was not detected in the 96 controls.
  • A known polymorphism, c.803T>C (p.Pro267Leu), was detected in 22 of the 93 patients and 15 of 48 controls. Statistical analysis (χ² test) showed no significant difference in genotype or allele frequencies between patients and controls for this polymorphism.
  • EPYC Variations: No variations were detected in the analyzed regions of the EPYC gene. Amplification of exon 5 of EPYC was unsuccessful.
  • Overall Conclusion: Based on these findings, the authors conclude that OPTC and EPYC are unlikely to play a major role in high myopia.

Limitations and Future Work

  • Limited Novel Variation: The most significant limitation is the identification of only one novel variation in OPTC, and even this variation was predicted to be tolerated by SIFT analysis. This single finding in a large cohort makes it difficult to establish a causal link to high myopia.
  • Incomplete EPYC Analysis: The inability to amplify exon 5 of EPYC means that the entire coding sequence of this gene was not fully evaluated, potentially missing relevant mutations. The high AT content in this region is cited as the reason.
  • Complex Disease Nature: The authors acknowledge that high myopia is a complex disease, likely influenced by multiple genes and environmental factors, making it challenging to pinpoint single-gene causes.
  • Future Work: The paper implies that further studies with larger cohorts and potentially different genetic approaches would be necessary to definitively rule out the involvement of OPTC and EPYC or to explore other candidate genes. The authors suggest that additional studies are needed to clarify these results.

Summary updated

Abstract

Only one novel variation in OPTC was detected in a Chinese patient with high myopia. Our results imply that OPTC and EPYC are unlikely to play a major role in high myopia.
BibTeX
@inproceedings{wang2009evaluation,
  author = {Panfeng Wang and Shiqiang Li and Xueshan Xiao and Xiangming Guo and Qingjiong Zhang},
  title = {{An evaluation of OPTC and EPYC as candidate genes for high myopia.}},
  booktitle = {PubMed},
  year = {2009},
}
Figure